Saul M. Genuth
#132,354
Most Influential Person Now
Saul M. Genuth's AcademicInfluence.com Rankings
Saul M. Genuthphilosophy Degrees
Philosophy
#6493
World Rank
#9537
Historical Rank
Logic
#3648
World Rank
#4840
Historical Rank

Download Badge
Philosophy
Saul M. Genuth's Degrees
- Doctorate Medicine University of California, San Francisco
Why Is Saul M. Genuth Influential?
(Suggest an Edit or Addition)Saul M. Genuth's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long‐Term Complications in Insulin‐Dependent Diabetes Mellitus (1993) (19715)
- Report of the expert committee on the diagnosis and classification of diabetes mellitus. (1999) (11399)
- Effects of intensive glucose lowering in type 2 diabetes. (2008) (4946)
- Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. (2005) (4036)
- Follow-up report on the diagnosis of diabetes mellitus. (2003) (3690)
- International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes (2009) (2534)
- A randomized trial of therapies for type 2 diabetes and coronary artery disease. (2009) (1778)
- Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. (2000) (1434)
- Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial (2010) (1192)
- Effects of medical therapies on retinopathy progression in type 2 diabetes. (2010) (1073)
- Long-term effects of intensive glucose lowering on cardiovascular outcomes. (2011) (950)
- Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. (2003) (832)
- Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. (2002) (816)
- Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). (2009) (594)
- Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. (1999) (552)
- Lowering the criterion for impaired fasting glucose is in order. (2003) (541)
- Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. (2007) (530)
- Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial—Revisited (2008) (460)
- Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Contro (1999) (441)
- Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial (2010) (431)
- The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study (2010) (420)
- Diabetes Control and Complications Trial (DCCT): Results of Feasibility Study. The DCCT Research Group (1987) (415)
- Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. (2005) (407)
- Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials (2011) (393)
- Implications of the United kingdom prospective diabetes study. (2003) (300)
- The Effect of Intensive Glycemic Treatment on Coronary Artery Calcification in Type 1 Diabetic Participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study (2006) (258)
- Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions (2013) (247)
- Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. (2007) (234)
- The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. (2014) (232)
- Evaluating the Role of Epigenetic Histone Modifications in the Metabolic Memory of Type 1 Diabetes (2014) (196)
- Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort (2016) (173)
- Glycation Products as Markers and Predictors of the Progression of Diabetic Complications (2005) (166)
- Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes. (2006) (154)
- Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes (2016) (148)
- Insulin Use in NIDDM (1990) (136)
- Plasma insulin and glucose profiles in normal, obese, and diabetic persons. (1973) (133)
- Development and validation of GFR-estimating equations using diabetes, transplant and weight. (2010) (126)
- Insulin resistance in genetically obese, hyperglycemic mice. (1971) (122)
- Weight reduction in obesity by outpatient semistarvation. (1974) (118)
- Skin Advanced Glycation End Products Glucosepane and Methylglyoxal Hydroimidazolone Are Independently Associated With Long-term Microvascular Complication Progression of Type 1 Diabetes (2014) (112)
- Carnitine metabolism in normal-weight and obese human subjects during fasting. (1980) (107)
- Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study (2016) (104)
- Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial (DCCT). (2010) (102)
- Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. (2006) (101)
- Classification and diagnosis of diabetes mellitus. (1982) (97)
- Effect of dietery weight loss on sex steroid binding sex steroids, and gonadotropins in obese postmenopausal women. (1979) (93)
- Exogenous Insulin Administration and Cardiovascular Risk in Non-Insulin-dependent and Insulin-dependent Diabetes Mellitus (1996) (92)
- Control of Hyperglycemia in Adult Diabetics by Pulsed Insulin Delivery (1977) (87)
- Metabolic Clearance of Insulin in Man (1972) (85)
- Myocardial Structure, Function, and Scar in Patients With Type 1 Diabetes Mellitus (2011) (83)
- Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study (2016) (81)
- Profibrinolytic, Antithrombotic, and Antiinflammatory Effects of an Insulin-Sensitizing Strategy in Patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial (2011) (73)
- Plasma and Urine Carnitine in Diabetic Ketosis (1979) (72)
- Supplemented fasting as a large-scale outpatient program. (1977) (72)
- The Hemoglobin Glycation Index Is Not an Independent Predictor of the Risk of Microvascular Complications in the Diabetes Control and Complications Trial (2007) (71)
- Rosiglitazone and Outcomes for Patients With Diabetes Mellitus and Coronary Artery Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial (2013) (67)
- Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. (2012) (66)
- Aldosterone secretion in anephric patients. (1972) (62)
- Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE). (2007) (61)
- Comparative response to parathyroid hormone in hyperthyroidism and hypothyroidism. (1975) (60)
- Forum One: Current Recommendations about Intensification of Metabolic Control in Non-Insulin-dependent Diabetes Mellitus (1996) (60)
- A RADIOIMMUNOLOGICAL ASSAY METHOD FOR INSULIN USING INSULIN-125I AND GEL FILTRATION. (1965) (59)
- Clinical implications of the ACCORD trial. (2012) (58)
- Glucosepane: a poorly understood advanced glycation end product of growing importance for diabetes and its complications (2014) (57)
- Implications of the Diabetes Control and Complications Trial. (2003) (56)
- The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes. (2013) (52)
- Supplemented fasting in the treatment of obesity and diabetes. (1979) (50)
- Baseline Characteristics of Patients with Diabetes and Coronary Artery Disease Enrolled in the BARI 2D Trial (2008) (50)
- Constant intravenous insulin infusion in diabetic ketoacidosis. (1973) (49)
- Hyperinsulinism in mice with genetically determined obesity. (1969) (49)
- Functioning primary thyroid carcinoma and metastases producing hyperthyroidism. (1971) (49)
- Should Sulfonylureas Remain an Acceptable First-Line Add-on to Metformin Therapy in Patients With Type 2 Diabetes? No, It’s Time to Move On! (2014) (49)
- Osteomalacia accompanying chronic anticonvulsant therapy. (1972) (48)
- STIMULATION OF INSULIN RELEASE BY CORICOTROPIN. (1965) (45)
- Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes (2015) (44)
- Coprogression of Cardiovascular Risk Factors in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study (2016) (43)
- Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. (2008) (43)
- The case for blood glucose control. (1995) (41)
- Haptoglobin Genotype and the Rate of Renal Function Decline in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (2013) (39)
- Effect of dexamethasone on oral glucose tolerance in healthy adults. (2010) (38)
- Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy (1988) (38)
- The UKPDS and its global impact (2008) (37)
- Binding of Insulin by Monkey and Pig Hypothalamus (1983) (37)
- Urinary excretion of acetylcarnitine during human diabetic and fasting ketosis. (1982) (36)
- Effects of Prior Intensive Versus Conventional Therapy and History of Glycemia on Cardiac Function in Type 1 Diabetes in the DCCT/EDIC (2013) (36)
- Effects of Prolonged Fasting on Insulin Secretion (1966) (35)
- Plasma parathormone, calcium and phosphorus in patients with renal osteodystrophy undergoing chronic hemodialysis. (1970) (34)
- Long-term effect of diabetes and its treatment on cognitive function (2007) (34)
- Insulin Dose and Cardiovascular Mortality in the ACCORD Trial (2015) (34)
- Clinical Remission in Diabetes Mellitus: Studies of Insulin Secretion (1970) (33)
- Insulin secretion in obesity and diabetes: an illustrative case. (1977) (32)
- Acute hormonal effects on carnitine metabolism in thin and obese subjects: responses to somatostatin, glucagon, and insulin. (1981) (30)
- Effect of oral alanine on blood beta-hydroxybutyrate and plasma glucose, insulin, free fatty acids, and growth hormone in normal and diabetic subjects. (1974) (30)
- Multiple endocrine adenomas in a patient with the Maffucci syndrome. (1976) (29)
- Effects of oral alanine administration in fasting obese subjects. (1973) (29)
- Management of the adult onset diabetic with sulfonylurea drug failure. (1992) (27)
- Self-reported prevalence of diabetes screening in the U.S., 2005-2010. (2014) (27)
- Laxative-induced hypokalemia, sodium depletion and hyperreninemia. Effects of potassium and sodium replacement on the renin-angiotensin-aldosterone system. (1975) (26)
- The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes (2016) (25)
- Hypoparathyroidism and Paget's disease: the effect of parathyroid hormone administration. (1972) (24)
- Hyperinsulinism in obese diabetic Pima Indians. (1967) (24)
- Oral calcium absorption in patients with renal failure treated by chronic hemodialysis. (1969) (24)
- DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes (2020) (24)
- Observations on the Value of Mass Indiscriminate Screening for Diabetes Mellitus Based on a Five-year Follow-up (1978) (22)
- Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes (2016) (21)
- Therapeutic controversy: Pancreas transplantation for type I diabetes. (1998) (21)
- Unilateral renal plasma flow in the assessment of correctable renovascular hypertension. (1965) (20)
- Clinical Diabetes Mellitus—A Problem-Oriented Approach (1987) (19)
- The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study: 30th Anniversary Presentations (2013) (19)
- A Step Backward—or Is it Forward? The opinions expressed in this article are those of the authors and do not necessarily reflect the views of the American Diabetes Association. (2008) (19)
- Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes: response to McCarter et al. (2005) (19)
- Relationships between the structure and biological activities of corticotropin and related peptides: hyperglycemic action of N-acetylated corticotropin related peptides. (1966) (18)
- Pancreas Transplantation for Type 1 Diabetes— A Summation (1998) (18)
- CARNITINE AND CARNITINE PALMITOYLTRANSFERASE IN METABOLIC STUDIES1 (1980) (17)
- Potentiation of levodopa stimulation of human growth hormone by systemic decarboxylase inhibition (1973) (16)
- Experience with low-dose insulin infusion in diabetic ketoacidosis and diabetic hyperosmolarity. (1978) (15)
- Quantitation of the pathways of fructose metabolism in normal and fructose-intolerant subjects. (1971) (15)
- Persistent hypoglycemia and hyperinsulinemia: caution in using glucagon. (1996) (15)
- Pancreas transplantation for type I diabetes (1998) (14)
- Diabetic ketoacidosis and hyperglycemic hyperosmolar coma. (1994) (14)
- Evolution of the study coordinator role: The 28-year experience in Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) (2012) (13)
- Review of three decades of laboratory exercises in the preclinical curriculum at the Case Western Reserve University School of Medicine (1992) (13)
- DEMONSTRATION OF IMMUNOLOGICAL SIMILARITIES OF HUMAN PREGNANCY GONADOTROPIN AND CHORIOCARCINOMA GONADOTROPIN WITH ANTISERA PREPARED IN RABBITS AND MONKEYS. (1964) (13)
- Triglyceride High-Density Lipoprotein Ratios Predict Glycemia-Lowering in Response to Insulin Sensitizing Drugs in Type 2 Diabetes: A Post Hoc Analysis of the BARI 2D (2015) (13)
- Community Screening for Diabetes by Blood Glucose Measurement: Results of a Five-year Experience (1976) (13)
- Normalization of Insulin Delivery to Diabetics by Pulsed Insulin Infusion (1977) (12)
- Urinary 3-hydroxyadipic acid 3,6-lactone: structural identification and effect of fasting in adults and children. (1989) (12)
- Simplified measurement of glomerular filtration rate. (1971) (12)
- Implications of the United Kingdom prospective diabetes study for patients with obesity and type 2 diabetes. (2000) (12)
- Effect of high fat vs. high carbohydrate feeding on the development of obesity in weanling ob/ob mice (1976) (9)
- Insulin response to intravenous alimentation. (1973) (9)
- Factitious Diabetic Instability (1985) (9)
- Diabetes Management in the 80s: The Role of Home Blood Glucose Monitoring and New Insulin Delivery Systems (1983) (9)
- Diabetic ketoacidosis and hyperglycemic hyperosmolar coma. (1997) (8)
- Precautions with supplemented fasting. (1977) (8)
- Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC (2022) (8)
- A case of idiopathic hypoparathyroidism and dietary vitamin D deficiency: the requirement for calcium and vitamin D for bone, but not renal responsiveness to PTH. (1977) (8)
- Severe hypoglycaemia in Diabetes Control and Complications Trial (1994) (7)
- For aggressive preventive management of type 2 diabetes. What is the evidence and is it enough? (1998) (7)
- Plasma Insulin Response to an Oral Carbohydrate Solution (1969) (6)
- Focal segmental glomerulosclerosis in idiopathic membranous glomerulonephritis: a clinico-pathological and stereological study (2010) (5)
- CHAPTER 1 CLASSIFICATION AND DIAGNOSIS OF DIABETES (2016) (5)
- Intractable ascites. Surgical management with reduction in secondary hyperaldosteronism. (1976) (4)
- Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study (2018) (4)
- Discordant Imaging of a Thyroglossal Duct Cyst (1981) (4)
- The burden of treatment failure in type 2 diabetes: response to Brown et al. (2005) (4)
- Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study (2018) (4)
- How Does Pioglitazone Prevent Progression of Impaired Glucose Tolerance to Diabetes? (2013) (3)
- Erratum to: Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes (2015) (2)
- Coronary Heart Disease Profibrinolytic , Antithrombotic , and Antiinflammatory Effects of an Insulin-Sensitizing Strategy in Patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes ( BARI 2 D ) Trial (2011) (2)
- Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial". (2014) (2)
- Response to Comment on Genuth. Should Sulfonylureas Remain an Acceptable First-Line Add-on to Metformin Therapy in Patients With Type 2 Diabetes? No, It’s Time to Move On! Diabetes Care 2015;38:170–175 (2015) (2)
- BARI 2D: A Reanalysis Focusing on Cardiovascular Events. (2019) (2)
- DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes (2020) (2)
- Response to Comment on: Lachin et al. (2007) The Hemoglobin Glycation Index Is Not an Independent Predictor of the Risk of Microvascular Complications in the Diabetes Control and Complications Trial: Diabetes 56:1913–1921, 2007 (2008) (2)
- Clinical utility of C-peptide measurement in diabetes mellitus. (1996) (2)
- Relationship Between Metabolic Control and Complications in Diabetes (2003) (2)
- Determinants of successful glycemic control among participants in the BARI 2D trial: a post-hoc analysis. (2014) (2)
- The role of the National Diabetes Advisory Board in diabetes management. (1994) (2)
- Abuse of the supplemented fast. (1977) (1)
- Intensive Treatment of Type-1 Diabetes The Balance of Benefits and Risks in the DCCT/EDIC Study (2006) (1)
- Alanine administration during prolonged fasting. (1971) (1)
- Data sharing is desirable, but benefits should not be exaggerated (2015) (1)
- Skin Collagen-Linked Fluorescence Predicts Atherosclerosis Progression in the Epidemiology of Diabetes Interventions and Complications (EDIC) Study (2005) (1)
- The Role of Diabetes Care and Its Contributions to the Field of Diabetes: A Profile in Progress (2018) (1)
- Is NIDDM Just a Receptor Disease? (1981) (1)
- Efficacy of instant glucose. (1979) (1)
- Summary and perspectives on impaired glucose tolerance. (1996) (1)
- Constant intravenous insulin infusion in diabetic ketoacidosis (1973) (1)
- United Kingdom prospective diabetes study results are in. (1998) (1)
- Mixed messages on systemic therapies for diabetic retinopathy – Authors' reply (2010) (1)
- Type II Diabetes Mellitus (2020) (0)
- Symposium: obese-hyperglycaemic mice (1972) (0)
- Proceedings of the NATIONAL ACADEMY- OF S(C -NCES (2004) (0)
- Early termination of the Diabetes Control and Complications Trial (2006) (0)
- Insulin secretion in vivo, correlation with insulin resistance. Abstr. (1972) (0)
- Effect of somatostatin on carnitine metabolism (1979) (0)
- CLINICAL VARIATIONS HOLD IMPORTANT CLUES TO THE UNDERSTANDING AND IMPLEMENTATION OF THE DCCT RESULTS. AUTHORS' REPLIES (1996) (0)
- Renal glomerular osteodystrophy. (1972) (0)
- Independence of Paget's Disease of Bone from Parathyroid Hormone. (1971) (0)
- How should diabetes be treated to minimize the risk of cardiovascular complications (2009) (0)
- Renal Osteodystrophy During Chronic Dialysis. (1969) (0)
- Cardiovascular function in type 1 diabetes: the DCCT/EDIC Research Group (2009) (0)
- in nomad and fruchw-inttrlerant sub+ts (1971) (0)
- A medical emancipation proclamation. (2000) (0)
- The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes (2016) (0)
- Response to Moses (1996) (0)
- Laxative-Induced Hypokalemia, Sodium Depletion and Hyperreninemia (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Saul M. Genuth?
Saul M. Genuth is affiliated with the following schools: